accepted and acknowledged
on 27 Sep 2024
Last Applicant/ Owned by
10628 Science Center Drive, Suite 250
San Diego
CA
92121
Serial Number
86170462 filed on 21st Jan 2014
Registration Number
5438472 registered on 03rd Apr 2018
Correspondent Address
Gabrial L. Mitchell
Gabrial L. Mitchell BAKER & HOESTETLER LLP
Washington Square, Suite 1100
Washington, DC 20036-5403
United States
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
Pharmaceutical preparations, namely, a lipid-enabled drug delivery system for RNA medicines comprising small interfering RNA, messenger RNA, antisense and microRNA oligotherapeutic agents to enable the targeting of any gene in the human genome, sold to pharmaceutical companies as an integral component for use in the further manufacture of pharmaceutical preparations for the treatment of a wide var Read More
Pharmaceutical preparations, namely, a lipid-enabled drug delivery system for RNA medicines comprising small interfering RNA, messenger RNA, antisense and microRNA oligotherapeutic agents to enable the targeting of any gene in the human genome, sold to pharmaceutical companies as an integral component for use in the further manufacture of pharmaceutical preparations for the treatment of a wide variety of diseases, including rare and orphan diseases
08th Feb 2016
08th Feb 2016
No 86170462
No Service/Collective Mark
No 101845.00007
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
27th Sep 2024 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED |
27th Sep 2024 | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
27th Sep 2024 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
26th Mar 2024 | TEAS SECTION 8 & 15 RECEIVED |
03rd Apr 2023 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
03rd Apr 2018 | REGISTERED-PRINCIPAL REGISTER |
02th Mar 2018 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
01st Mar 2018 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
21st Feb 2018 | STATEMENT OF USE PROCESSING COMPLETE |
12th Feb 2018 | USE AMENDMENT FILED |